| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 7.390 | 16.205 | 44.445 | 86.024 | 51.960 |
| Total Income - EUR | - | - | - | - | - | 7.390 | 16.205 | 44.445 | 86.025 | 51.960 |
| Total Expenses - EUR | - | - | - | - | - | 82 | 257 | 9.570 | 17.643 | 39.298 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 7.308 | 15.948 | 34.875 | 68.382 | 12.662 |
| Net Profit/Loss - EUR | - | - | - | - | - | 7.086 | 15.462 | 34.113 | 67.522 | 11.103 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Pecamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 1.986 | 1.671 | 35.143 |
| Current Assets | - | - | - | - | - | 7.349 | 17.554 | 33.300 | 67.549 | 9.239 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 145 | 240 | 6.156 | 56.560 | 3.733 |
| Cash | - | - | - | - | - | 7.205 | 17.315 | 27.144 | 10.989 | 5.506 |
| Shareholders Funds | - | - | - | - | - | 7.128 | 17.378 | 34.308 | 67.563 | 14.847 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 222 | 176 | 978 | 1.658 | 29.535 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pecamed S.r.l.